Global High-Throughput Screening Market: Overview
The high-throughput screening is a technique in drug discovery utilized for evaluation and screening of huge numeral of biological effectors and modulators against the selected target. The high-throughput screening techniques are also utilized to characterize pharmacokinetic, toxicological and metabolic information for new drugs and thus, subsequently reduce the price of the drug development. The high-throughput screening consists of various stages, including reagent preparation, target identification, assay development, high-throughput library screening, and compound management. Thus, the increasing demand for high-throughput screening, the market is expected to propel in the near future.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/high-throughput-screening-market
Global High-Throughput Screening Market: Growth Factors
The increasing government funding, rising R&D expenditure, elevating acceptance of innovative models in the biotechnology & pharmaceutical industry, and enhancement in technologies such as miniaturization & automation are few factors that are responsible for the growth of the market for high-throughput screening. Furthermore, the increasing research activities in stem cells & toxicology and developing markets are expected to drive the market growth. However, the high time consumption and a high price of the high-throughput screening techniques are factors that can hinder the growth of the market.
Global High-Throughput Screening Market: Segmentation
The global high-throughput screening market can be segmented based on application, end-user, services & products, technology, and region. The application segment of the market is classified into the primary screening, target identification, toxicology assessment, and other applications. The end-user segment of the market is divided into contract research organizations, pharmaceutical & biotechnology companies, and academic & government research institutes, and other end-users. The services & products segment of the high-throughput screening market is diversified into instruments, consumables and reagents, and software & services. The technology segment of the market is grouped into perfusion cell culture, 2D cell culture, cell-based assays, and 3D cell culture. The 3D cell culture market is sub-segmented into scaffold-free technologies and scaffold-based technologies. The Scaffold-free Technologies is categorized into ultra-low binding plates, hanging-drop plates, microplate, and other scaffold-free technologies. The scaffold-based technologies segment of the high-throughput screening market is classified into inert matrix/solid scaffolds and hydrogels.
Global High-Throughput Screening Market: Regional Analysis
North America is anticipated to dominate the global high-throughput screening market in the near future due to the rising application of cell culture and cell line methodologies in cancer research, the rising acceptance of low-cost technology in the clinical diagnostic laboratories, and growing excellence of infrastructure for clinical and laboratory research. Asia Pacific region is also assumed to grow in the market in the coming period due to the improvement in technologies in the emerging economies.
Global High-Throughput Screening Market: Competitive Players
The key players in the global high-throughput screening market are Thermo Fisher Scientific, Merck Millipore, Agilent Technologies, Inc., Tecan Group Ltd., and PerkinElmer, Inc. The other prominent players in the market are Bio-Rad laboratories, Axxam S.p.A., Hamilton Company, Aurora Biomed, and Danaher Corporation, Inc.